A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia

Nicholas J. Short, Hagop Kantarjian, Elias Jabbour, Jorge E. Cortes, Deborah A. Thomas, Michael E. Rytting, Naval Daver, Yesid Alvarado, Marina Konopleva, Partow Kebriaei, William G. Wierda, Courtney D. DiNardo, Carol Bivins, Deborah McCue, Mary A. Richie, Farhad Ravandi

Research output: Contribution to journalLetter

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)442-444
Number of pages3
JournalBritish Journal of Haematology
Volume182
Issue number3
DOIs
Publication statusPublished - Aug 2018
Externally publishedYes

Keywords

  • CD22
  • acute lymphoblastic leukaemia
  • immunotoxin
  • moxetumomab pasudotox
  • relapsed/refractory

ASJC Scopus subject areas

  • Hematology

Cite this